erythromycin has been researched along with Communicable Diseases, Emerging in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Weir, E | 1 |
| Brown, SD; Farrell, DJ; Jenkins, SG; Klugman, KP; Lavin, BS; Patel, M | 1 |
3 other study(ies) available for erythromycin and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Resurgence of Bordetella pertussis infection.
Topics: Anti-Bacterial Agents; Bordetella Infections; Bordetella pertussis; Canada; Child; Child, Preschool; Communicable Diseases, Emerging; Diphtheria-Tetanus-Pertussis Vaccine; Erythromycin; Humans; Immunization Schedule; Infant | 2002 |
Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Communicable Diseases, Emerging; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Infant; Infant, Newborn; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pneumococcal Infections; Population Surveillance; Respiratory Tract Infections; Streptococcus pneumoniae | 2005 |